Announcements

MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

• Biology and Life Sciences;
• Business and Economics;
• Chemistry and Materials Sciences;
• Computer Sciences and Mathematics;
• Engineering;
• Environmental and Earth Sciences;
• Medicine and Pharmacology;
• Social Sciences, Arts and Humanities;
• Physical Sciences;
• Public Health and Healthcare.

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held the Editorial Board Meeting for the “Infectious Diseases” Section on 17 March 2026. The meeting was hosted by the Section’s Editor-in-Chief, Prof. Dr. Robert Flisiak, with seven Editorial Board Members in attendance to discuss the development of the “Infectious Diseases” Section. We sincerely appreciate the valuable insights and constructive suggestions shared by members. We also welcome additional members to participate in our future online meetings and conference booths. In addition, we encourage members to share their suggestions and ideas at any time, and welcome further communication with the JCM Editorial Office (jcm@mdpi.com) or Journal Relations (jr-jcm@mdpi.com). We look forward to continued collaboration to advance the development of the “Infectious Diseases” Section and promote the dissemination of clinical and infectious disease knowledge.

The meeting commenced with an overview presentation covering key information about the journal and its “Infectious Diseases” Section, as detailed below:

• The journal’s performance data, distribution of scholars, editorial procedure details, and paper promotion channels;
• The journal’s diverse marketing activities, including conference sponsorship, free online webinars, virtual conferences (IOCCM 2026), social media accounts, awards, and society collaborations;
• Publication statistics of the “Infectious Diseases” Section over the past three years, the most popular publications and Special Issues within two years, the most active member, and an overview of the Section Members.

The following topics were discussed at this Editorial Board meeting:

• Members discussed future research directions and potential Special Issue topics, and recommended several topics;
• Members discussed the journal’s quality and editorial standards. We will continue to maintain a rigorous peer review process and adhere to ethical guidelines;
• Members are concerned about excessive AI use in manuscript writing, and we have shared the journal’s relevant supervision and review standards.
• Members recommended improving the quality and formatting of tables in published articles.

Attendee list (ordered alphabetically):

• Dr. Daniel Scott-Algara, Institut Pasteur, France;
• Dr. Emanuele Pontali, Galliera Hospital, Italy;
• Prof. Dr. Hiroshi Nishiura, Kyoto University, Japan;
• Prof. Dr. Jean-Francois Timsit, ¹ APHP Bichat Hospital F, France; ² Université Paris Cité, France;
• Prof. Dr. Robert Flisiak (Section Editor-in-Chief), Medical University of Białystok, Poland;
• Dr. Samantha S. Soldan, Wistar Institute, USA;
• Dr. Wojciech Rozek, National Veterinary Research Institute, Poland;
• Dr. Yasmin Maor, ¹ Wolfson Medical Center, Israel; ² Tel Aviv University, Israel.

To access additional statistics for the “Infectious Diseases” Section, please click here.

We welcome you to participate in the free online conference, “The 4th International Online Conference on Clinical Medicine” (IOCCM 2026), which includes the “Infectious Diseases” topic. Abstract submissions for this conference are open until 7 August 2026.

For further details, please visit https://www.mdpi.com/journal/jcm/events.

As a pioneer in open access publishing, MDPI maintains rigorous publication standards. This mission relies on the dedication and expertise of our reviewers, who invest their time and knowledge to ensure the quality and integrity of the research we publish.

In 2025, over 209,000 reviewers contributed to the peer-review process at MDPI, providing more than 1.3 million review reports for our journals. To express our gratitude, MDPI’s Reviewer Recognition Program highlights reviewers across over 400 journals, featuring those who have assessed at least one manuscript and agreed to be acknowledged.

In addition, MDPI has identified its Top 1000 Reviewers of 2024 to recognize those whose expertise, dedication, and thoughtful evaluations were particularly outstanding.

Many journals have also established Outstanding Reviewer Awards to honor our reviewers’ commitment to publication excellence. Together with the Exceptional Reviewer List, we showcase the importance of reviewers’ work and their time and dedication.

These initiatives serve to express our deepest appreciation and gratitude towards the whole reviewer community. In recognition of their contributions, we also welcome new researchers to join this community. If you would like to contribute to open access publishing, learn more about the reviewers’ benefits and sign up to join us.

Conference: the Swiss Congress of Radiology 2026 (SCR’26)
Date: 28–30 May 2026
Place: Lausanne, Switzerland
Conference website: https://congress.sgr-ssr.ch/

We are pleased to announce that MDPI will be participating as an exhibitor at the Swiss Congress of Radiology 2026 (SCR’26), which will be held on from 28 to 30 May 2026, in the SwissTech Convention Center of the EPFL in Lausanne.

The Swiss Society of Radiology (SGR-SSR) and its associated societies (SGPR-SSRP, SSVIR, SSER, SSSR, SSRMP), as well as the SVMTR-ASTRM (Swiss Association of Radiographers) and the SGNM-SSMN (Swiss Society of Nuclear Medicine), are making a great effort to develop an attractive programme over three days. It includes many educational and scientific sessions, exciting lectures covering the entire spectrum of diagnostic and interventional radiology, and more dedicated sessions for each subspeciality. For this, renowned national and international speakers have been invited.

As part of our commitment to supporting high-quality research in these fields, MDPI is proud to sponsor the event through the participation of the following journals:

• Diagnostics;
• JCM;
• Tomography;
• Uro;
• Biophysica;
• Radiation.

Our editorial team will be available on-site and would be delighted to meet with attendees. If you are attending the conference, feel free to stop by our booth to learn more about our open access publishing opportunities, ongoing Special Issues, and how we support researchers in advancing their work.

We look forward to meeting you in Lausanne!

Tuberculosis is a disease that is both preventable and treatable, significantly affecting people’s health and quality of life worldwide. Every year, we commemorate World Tuberculosis Day to raise public awareness of the devastating health, social, and economic consequences of tuberculosis (TB) and to intensify efforts to end the global TB epidemic. The date signifies the day in 1882 when Dr. Robert Koch announced his discovery of the bacterium responsible for TB, which paved the way for diagnosing and curing this disease.

The theme of World TB Day 2026, “Yes! We can End TB! Led by Countries, Powered by People”, is a bold call to action and a message of hope, affirming that it is possible to get back on track and turn the tide on the TB epidemic, even in a challenging global environment. With decisive country leadership, increased domestic and international investment, rapid uptake of new WHO recommendations and innovations, accelerated action, and strong multisectoral collaboration, ending TB is not just aspirational—it is achievable.

We hope that established journals in the fields of biology, life sciences, medicine, and pharmacology at MDPI will continue to serve as a communication platform for innovative ideas regarding prevention and treatment.

 “Trends in Tuberculosis Incidence and Mortality in South Africa and Bulgaria (2000–2023): The Impact of Income, Poverty, Unemployment, and Universal Health Coverage”
by Siyabonga Kave, Joana Simeonova, Antoniya Yanakieva, Alexandrina Vodenitcharova, Denisha Govender, Yandisa Sikweyiya and Nelisiwe Khuzwayo
Epidemiologia 2026, 7(2), 39; https://doi.org/10.3390/epidemiologia7020039

“Humoral Immune Activation Against Mycobacterium avium subsp. paratuberculosis Through Oral Immunization with Engineered Salmonella”
by Azar Motamedi Boroojeni, Nikoo Veiskarami, Elena Rita Simula, Leonardo Antonio Sechi and Abdollah Derakhshandeh
Bacteria 2025, 4(3), 47; https://doi.org/10.3390/bacteria4030047

“History of Pulmonary Tuberculosis Accelerates Early Onset and Severity of COPD: Evidence from a Multicenter Study in Romania”
by Ramona Cioboata, Silviu Gabriel Vlasceanu, Denisa Maria Mitroi, Ovidiu Mircea Zlatian, Mara Amalia Balteanu, Gabriela Marina Andrei, Viorel Biciusca and Mihai Olteanu
J. Clin. Med. 2025, 14(17), 5980; https://doi.org/10.3390/jcm14175980

“Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery”
by Sameeullah Memon, Shabana Bibi and Guozhong He
Diseases 2025, 13(6), 184; https://doi.org/10.3390/diseases13060184

“Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children”
by Amanda de O. E. Moreira, Lêda Maria S. Azevedo Neta, Márcia Pietroluongo, Ana Paula dos S. Matos, Beatriz B. Correa, Beatriz H. Ortiz, André da S. Guimarães, Marcio Nele, Carollyne M. Santos, Ana Elizabeth C. Fai et al.
Pharmaceutics 2025, 17(5), 658; https://doi.org/10.3390/pharmaceutics17050658

“Prevalence and Associated Factors of Latent Tuberculosis Infection Among Healthcare Workers in a Mexican Tertiary Care Hospital”
by José Ángel Hernández-Mariano, Mónica Alethia Cureño-Díaz, Verónica Fernández-Sánchez, Estibeyesbo Said Plascencia-Nieto, Dulce Milagros Razo-Blanco-Hernández, Claudia Vázquez-Zamora, Víctor Hugo Gutiérrez-Muñoz, Beatriz Leal-Escobar, Erika Gómez-Zamora and Yanelly Estrella Morales-Vargas
Diseases 2025, 13(6), 173; https://doi.org/10.3390/diseases13060173

“The Complex Relationship Between Tuberculosis and Hyperglycemia”
by Michelle Byers and Elizabeth Guy
Diagnostics 2024, 14(22), 2539; https://doi.org/10.3390/diagnostics14222539

“The Role of mTOR in Mycobacterium tuberculosis Infection”
by Ami Patel, Lannhi Nguyen, Christina Shea, Sunjum Singh and Vishwanath Venketaraman
Biomedicines 2024, 12(10), 2238; https://doi.org/10.3390/biomedicines12102238

“Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country”
by Agnese Colpani, Davide Astorri, Andrea De Vito, Giordano Madeddu, Sandro Panese and Nicholas Geremia
Reports 2024, 7(4), 82; https://doi.org/10.3390/reports7040082

“Adherence to Short-Duration Treatment (3HP) for Latent Tuberculosis among International Migrants in Manaus, Amazonas: Evaluation of the Efficacy of Different Treatment Modalities”
by Yan Mathias Alves, Thaís Zamboni Berra, Sonia Vivian de Jezus, Vânia Maria Silva Araújo, Jair dos Santos Pinheiro, Lara Bezerra de Oliveira de Assis, Marvis Canelonez, Daniel Souza Sacramento, Freddy Perez, Ethel Leonor Noia Maciel et al.
Microorganisms 2024, 12(8), 1629; https://doi.org/10.3390/microorganisms12081629

“A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature”
by Maria Filoftea Mercut, Oana Maria Ică, Cornelia Andreea Tănasie, Răzvan Mercuț, Carmen Luminița Mocanu, Andreea Mihaela Nicolcescu and Ciprian Danielescu
J. Pers. Med. 2024, 14(3), 235; https://doi.org/10.3390/jpm14030235

“Mycobacterium tuberculosis Deficient in PdtaS Cytosolic Histidine Kinase Displays Attenuated Growth and Affords Protective Efficacy against Aerosol M. tuberculosis Infection in Mice”
by Kelly A. Prendergast, Gayathri Nagalingam, Nicholas P. West and James A. Triccas
Vaccines 2024, 12(1), 50; https://doi.org/10.3390/vaccines12010050

“Novel Therapeutic Agents and Innovative Delivery Systems Against Infectious Diseases” Guest Editor: Dr. Sara Consalvi Submission deadline: 30 June 2026	“Genomic Epidemiology & Drug Resistance in Mycobacterium tuberculosis” Guest Editors: Dr. Benson Kidenya and Dr. Gerald Mboowa Submission deadline: 30 June 2026
“Mycobacterial Infections and Human Disease: Emerging Mechanisms and Therapeutic Strategies/Boundaries” Guest Editors: Dr. Sameer Tiwari, Dr. Ashutosh Tripathi and Prof. Dr. Shahid Umar Submission deadline: 1 August 2026	“Recent Advances in Molecular and Cellular Approaches to Tuberculosis Pathogenesis, Treatment and Prevention” Guest Editor: Dr. Selvakumar Subbian Submission deadline: 20 August 2026
“Personalized Medicine in Epidemiology and Infectious Diseases” Guest Editors: Prof. Dr. Takalani Grace Tshitangano and Prof. Dr. Daniel Ter Goon Submission deadline: 20 September 2026	“Biomolecules in Mycobacterial Pathogenesis, Host–Pathogen Interactions, and Antimicrobial and Therapeutic Approaches” Guest Editor: Dr. Cinzia Marianelli Submission deadline: 31 December 2026

We are delighted to share Notable Perspectives Papers from the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These selected papers have drawn significant attention and cover our 12 sections, including but not limited to respiratory medicine, nephrology & urology, and nuclear medicine & radiology. We sincerely thank our Editorial Board Members for their valuable contributions, and we invite researchers from a wide range of clinical and research backgrounds to read these articles.

1. “Shaping the Future of Healthcare: Ethical Clinical Challenges and Pathways to Trustworthy AI”
by Polat Goktas and Andrzej Grzybowski
J. Clin. Med. 2025, 14(5), 1605; https://doi.org/10.3390/jcm14051605
Full text available online: https://www.mdpi.com/2077-0383/14/5/1605

2. “Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment”
by Pankaj Garg, Siddhika Pareek, Prakash Kulkarni, David Horne, Ravi Salgia and Sharad S. Singhal
J. Clin. Med. 2024, 13(21), 6537; https://doi.org/10.3390/jcm13216537
Full text available online: https://www.mdpi.com/2077-0383/13/21/6537

3. “Advancing Clinical Practice: The Potential of Multimodal Technology in Modern Medicine”
by Yaara Artsi, Vera Sorin, Benjamin S. Glicksberg, Girish N. Nadkarni and Eyal Klang
J. Clin. Med. 2024, 13(20), 6246; https://doi.org/10.3390/jcm13206246
Full text available online: https://www.mdpi.com/2077-0383/13/20/6246

4. “New Horizons of Artificial Intelligence in Medicine and Surgery”
by Valerii Luțenco, George Țocu, Mădălin Guliciuc, Monica Moraru, Iuliana Laura Candussi, Marius Dănilă, Verginia Luțenco, Florentin Dimofte, Oana Mariana Mihailov and Raul Mihailov
J. Clin. Med. 2024, 13(9), 2532; https://doi.org/10.3390/jcm13092532
Full text available online: https://www.mdpi.com/2077-0383/13/9/2532

5. “Application of Artificial Intelligence in Otology: Past, Present, and Future”
by Hajime Koyama, Akinori Kashio and Tatsuya Yamasoba
J. Clin. Med. 2024, 13(24), 7577; https://doi.org/10.3390/jcm13247577
Full text available online: https://www.mdpi.com/2077-0383/13/24/7577

6. “The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives”
by Matteo Marchetti, Jacopo Ferrari, Tommaso Vezzaro, Laura Masatti, Giulia Tasca, Tiziano Maggino, Roberto Tozzi, Carlo Saccardi, Marco Noventa and Giulia Spagnol
J. Clin. Med. 2024, 13(23), 7041; https://doi.org/10.3390/jcm13237041
Full text available online: https://www.mdpi.com/2077-0383/13/23/7041

7. “Kidney Damage in Pediatric Obesity: Insights from an Emerging Perspective”
by Gianmario Forcina, Margherita Luciano, Vittoria Frattolillo, Simona Mori, Noemi Monaco, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice and Anna Di Sessa
J. Clin. Med. 2024, 13(23), 7025; https://doi.org/10.3390/jcm13237025
Full text available online: https://www.mdpi.com/2077-0383/13/23/7025

8. “Hyperreflective Retinal Foci (HRF): Definition and Role of an Invaluable OCT Sign”
by Luisa Frizziero, Giulia Midena, Luca Danieli, Tommaso Torresin, Antonio Perfetto, Raffaele Parrozzani, Elisabetta Pilotto and Edoardo Midena
J. Clin. Med. 2025, 14(9), 3021; https://doi.org/10.3390/jcm14093021
Full text available online: https://www.mdpi.com/2077-0383/14/9/3021

9. “Nanoengineering Solutions for Cancer Therapy: Bridging the Gap between Clinical Practice and Translational Research”
by Pankaj Garg, Siddhika Pareek, Prakash Kulkarni, Ravi Salgia and Sharad S. Singhal
J. Clin. Med. 2024, 13(12), 3466; https://doi.org/10.3390/jcm13123466
Full text available online: https://www.mdpi.com/2077-0383/13/12/3466

10. “Controlled Mechanical Ventilation in Critically Ill Patients and the Potential Role of Venous Bagging in Acute Kidney Injury”
by Mark E. Seubert and Marco Goeijenbier
J. Clin. Med. 2024, 13(5), 1504; https://doi.org/10.3390/jcm13051504
Full text available online: https://www.mdpi.com/2077-0383/13/5/1504

11. “From Awake to Minimalist Spontaneous Ventilation Thoracoscopic Lung Surgery: An Ongoing Journey”
by Eugenio Pompeo
J. Clin. Med. 2025, 14(7), 2475; https://doi.org/10.3390/jcm14072475
Full text available online: https://www.mdpi.com/2077-0383/14/7/2475

12. “Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions”
by Alice De Bernardi, Cristina Bezzio, Michele Puricelli, Daniela Gilardi and Simone Saibeni
J. Clin. Med. 2025, 14(2), 590; https://doi.org/10.3390/jcm14020590
Full text available online: https://www.mdpi.com/2077-0383/14/2/590

13. “Balancing Ethics and Innovation: Can Artificial Intelligence Safely Transform Emergency Surgery? A Narrative Perspective”
by Belinda De Simone, Genevieve Deeken and Fausto Catena
J. Clin. Med. 2025, 14(9), 3111; https://doi.org/10.3390/jcm14093111
Full text available online: https://www.mdpi.com/2077-0383/14/9/3111

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an open access journal, and all published articles are freely available for reading and download.  Video abstracts are welcomed as an effective way for authors to present their research findings in a vivid and intuitive format. This approach creates a high-quality audiovisual experience that overcomes the limitations of traditional paper-based presentations. We are pleased to share selected papers with video abstracts published in 2024 and 2025, which we hope will provide valuable insights and reliable references for your related research.

1. “Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets”
by Allison B. Reiss, Berlin Jacob, Aarij Zubair, Ankita Srivastava, Maryann Johnson and Joshua De Leon
J. Clin. Med. 2024, 13(7), 1881; https://doi.org/10.3390/jcm13071881
Full text available online: https://www.mdpi.com/2077-0383/13/7/1881

2. “Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement”
by Eqram Rahman, Parinitha Rao, Hany Niamey Abu-Farsakh, Chirag Thonse, Imran Ali, Alice E. Upton, Shwetha Y. Baratikkae, Jean D. A. Carruthers, Ash Mosahebi, Nima Heidari et al.
J. Clin. Med. 2024, 13(15), 4571; https://doi.org/10.3390/jcm13154571
Full text available online: https://www.mdpi.com/2077-0383/13/15/4571

3. “Diagnostic Methods for the Prenatal Detection of Cleft Lip and Palate: A Systematic Review”
by Ana Baeza-Pagador, Ana Tejero-Martínez, Lucas Salom-Alonso, Sara Camañes-Gonzalvo, Verónica García-Sanz and Vanessa Paredes-Gallardo
J. Clin. Med. 2024, 13(7), 2090; https://doi.org/10.3390/jcm13072090
Full text available online: https://www.mdpi.com/2077-0383/13/7/2090

4. “The Role of Scanning Electron Microscopy in the Evaluation of Conjunctival Microvilli as an Early Biomarker of Ocular Surface Health: A Literature Review”
by Mario Troisi, Salvatore Del Prete, Salvatore Troisi, Antonio Del Prete, Carlo Bellucci, Daniela Marasco and Ciro Costagliola
J. Clin. Med. 2024, 13(24), 7569; https://doi.org/10.3390/jcm13247569
Full text available online: https://www.mdpi.com/2077-0383/13/24/7569

5. “Effects of a Tele-Prehabilitation Program with Indirect Electrostimulation Compared to Home-Based Exercise in Patients Eligible for Lower Limb Arthroplasty: A Randomized Controlled Trial”
by Pamela Patanè, Vittoria Carnevale Pellino, Massimiliano Febbi, Caterina Cavallo, Fabrizio Gervasoni, Alessandro Gatti, Emanuele Caldarella, Francesca de Caro, Matteo Vandoni, Federica Manzoni et al.
J. Clin. Med. 2025, 14(4), 1356; https://doi.org/10.3390/jcm14041356
Full text available online: https://www.mdpi.com/2077-0383/14/4/1356

6. “Platelet Reduction after Transcatheter Aortic Valve Implantation: Results from the PORTRAIT Study”
by Federica Jiritano, Michele Di Mauro, Giuseppe Filiberto Serraino, Pasquale Mastroroberto, Elena Caporali, Enrico Ferrari, Mariusz Kowalewski, Roberto Scrofani, Leonardo Patanè, Giuseppe Visicchio et al.
J. Clin. Med. 2024, 13(6), 1579; https://doi.org/10.3390/jcm13061579
Full text available online: https://www.mdpi.com/2077-0383/13/6/1579

7. “Telemedicine/Telerehabilitation to Expand Enhanced Recovery After Surgery Interventions in Minimally Invasive Mitral Valve Surgery”
by Pietro Giorgio Malvindi, Maria Gabriella Ceravolo, Marianna Capecci, Stefania Balestra, Emanuela Cinì, Antonia Antoniello, Lucia Pepa, Antonella Carbonetti, Maurizio Ricci, Paolo Berretta et al.
J. Clin. Med. 2025, 14(3), 750; https://doi.org/10.3390/jcm14030750
Full text available online: https://www.mdpi.com/2077-0383/14/3/750

8. “The Utility of Three-Dimensional Printing in Physician-Modified Stent Grafts for Aortic Lesions Repair”
by Wiktoria Antonina Zasada, Hubert Stępak, Magdalena Węglewska, Łukasz Świątek, Jerzy Kluba and Zbigniew Krasiński
J. Clin. Med. 2024, 13(10), 2977; https://doi.org/10.3390/jcm13102977
Full text available online: https://www.mdpi.com/2077-0383/13/10/2977

9. “Fluid Overload in Children Following Hematopoietic Cell Transplant: A Comprehensive Review”
by Lama Elbahlawan, Amr Qudeimat, Ray Morrison and Alexandra Schaller
J. Clin. Med. 2024, 13(21), 6348; https://doi.org/10.3390/jcm13216348
Full text available online: https://www.mdpi.com/2077-0383/13/21/6348

10. “The Human Disharmony Loop: The Anatomic Source Behind Subacromial Impingement and Pain”
by Ketan Sharma, Jaicharan Iyengar and James Friedman
J. Clin. Med. 2025, 14(16), 5650; https://doi.org/10.3390/jcm14165650
Full text available online: https://www.mdpi.com/2077-0383/14/16/5650

Dear Colleagues,

As Editor-in-Chief of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), I am pleased to announce the winners of the 2026 Travel Awards. The award has been granted to Mr. Michael Klowak, a PhD student at the University of Toronto, Canada, and Ms. Nikoleta Bizymi, a Post-doctoral fellow at the National and Kapodistrian University of Athens, Greece.

Mr. Michael Klowak will be awarded CHF 800 to attend the 43rd International Symposium on Diabetes and Nutrition (June 15-18, 2026), to be held in Tarragona, Spain. Ms. Nikoleta Bizymi will be awarded CHF 800 to attend the ERS Congress 2026 (September 5-9, 2026), to be held in Barcelona, Spain.

As awardees, they will each receive an honorarium of CHF 800 and an electronic certificate.

With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting a wide and fascinating range of research topics.

On behalf of the assessment committee, I congratulate the winners on their accomplishments.

Prof. Dr. Kent Doi
Editor-in-Chief of JCM
On behalf of the JCM 2025 Travel Award Evaluation Committee

This webinar will spotlight idiopathic/progressive condylar resorption (ICR/PCR), a rare but significant disorder affecting the temporomandibular joint (TMJ). Once joint breakdown begins, ICR/PCR can progress and lead to severe dentofacial deformities and functional impairment. Early diagnosis and appropriate management of skeletal changes are therefore essential to prevent irreversible joint damage. As ICR/PCR can present with varying degrees of condylar resorption, treatment strategies may range from noninvasive therapies to minimally invasive procedures and surgical interventions, depending on disease severity.

In this webinar, international experts will present the current understanding and management strategies for ICR/PCR, with a focus on both noninvasive and surgical treatment modalities aimed at restoring mandibular function, reducing pain, and improving dentofacial aesthetics. Researchers, clinicians, and industry professionals are warmly invited to join this session to gain insights into the latest advances and future directions in ICR/PCR diagnosis and management.

Date: 10 April 2026 at 06:00 a.m. CST Asia | 07:00 a.m. JST| 08:00 a.m. AEST
Webinar ID: 810 7110 4460
Website: https://sciforum.net/event/JCM-23

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations made with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will let you know when the recording is available to watch online.

Register now for free!

Program:

Webinar Chair and Speakers:

• Prof. Eiji Tanaka (Chair), Tokushima University Graduate School of Biomedical Sciences, Japan;
• Prof. Dr. Kotaro Tanimoto, Hiroshima University Graduate School of Biomedical Sciences, Japan;
• Prof. Dr. Louis Mercuri, Rush University Medical Center, USA.